Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 36 | 2020 | 951 | 3.540 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2020 | 1328 | 3.000 |
Why?
|
| Brain Mapping | 9 | 2018 | 178 | 2.800 |
Why?
|
| Brain Concussion | 8 | 2020 | 64 | 1.470 |
Why?
|
| Brain Diseases | 6 | 2018 | 38 | 1.350 |
Why?
|
| Football | 10 | 2020 | 79 | 1.330 |
Why?
|
| Image Interpretation, Computer-Assisted | 7 | 2018 | 112 | 1.260 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2017 | 226 | 1.180 |
Why?
|
| Spinal Fractures | 4 | 2012 | 43 | 1.040 |
Why?
|
| Algorithms | 5 | 2017 | 495 | 0.980 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2018 | 1428 | 0.950 |
Why?
|
| Marijuana Abuse | 2 | 2019 | 19 | 0.920 |
Why?
|
| Decision Making | 2 | 2019 | 195 | 0.780 |
Why?
|
| Nerve Net | 2 | 2014 | 123 | 0.770 |
Why?
|
| Humans | 72 | 2020 | 32114 | 0.760 |
Why?
|
| Male | 58 | 2020 | 19217 | 0.710 |
Why?
|
| Neuroradiography | 1 | 2019 | 2 | 0.690 |
Why?
|
| Sacrum | 3 | 2009 | 22 | 0.670 |
Why?
|
| Cognition Disorders | 8 | 2018 | 385 | 0.660 |
Why?
|
| Reward | 2 | 2019 | 64 | 0.660 |
Why?
|
| Communication | 1 | 2020 | 142 | 0.660 |
Why?
|
| Image Enhancement | 6 | 2014 | 72 | 0.630 |
Why?
|
| Rest | 2 | 2017 | 53 | 0.610 |
Why?
|
| Cognition | 8 | 2018 | 556 | 0.600 |
Why?
|
| Cerebrovascular Disorders | 4 | 2020 | 52 | 0.590 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2019 | 919 | 0.580 |
Why?
|
| Adolescent | 21 | 2020 | 3568 | 0.540 |
Why?
|
| Atlases as Topic | 1 | 2016 | 9 | 0.540 |
Why?
|
| Female | 44 | 2020 | 20015 | 0.530 |
Why?
|
| Magnetoencephalography | 2 | 2014 | 14 | 0.500 |
Why?
|
| African Americans | 9 | 2018 | 1425 | 0.490 |
Why?
|
| Craniocerebral Trauma | 4 | 2019 | 56 | 0.490 |
Why?
|
| Cerebrum | 1 | 2014 | 6 | 0.470 |
Why?
|
| Alzheimer Disease | 4 | 2019 | 327 | 0.430 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 3 | 2019 | 27 | 0.420 |
Why?
|
| Bone Cements | 2 | 2012 | 11 | 0.400 |
Why?
|
| Polymethyl Methacrylate | 2 | 2012 | 13 | 0.400 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1022 | 0.390 |
Why?
|
| Cerebrovascular Circulation | 6 | 2019 | 93 | 0.390 |
Why?
|
| Spin Labels | 7 | 2017 | 24 | 0.370 |
Why?
|
| Glucose | 5 | 2003 | 174 | 0.370 |
Why?
|
| Brain Neoplasms | 5 | 2020 | 638 | 0.370 |
Why?
|
| Athletes | 4 | 2019 | 69 | 0.360 |
Why?
|
| Models, Neurological | 1 | 2011 | 117 | 0.350 |
Why?
|
| Brain Injuries | 3 | 2015 | 93 | 0.350 |
Why?
|
| Radiosurgery | 3 | 2020 | 356 | 0.340 |
Why?
|
| Adult | 20 | 2020 | 9380 | 0.340 |
Why?
|
| Animals | 18 | 2020 | 7542 | 0.340 |
Why?
|
| Head Injuries, Closed | 3 | 2019 | 16 | 0.340 |
Why?
|
| Positron-Emission Tomography | 4 | 2020 | 163 | 0.330 |
Why?
|
| Microtubules | 2 | 2020 | 23 | 0.330 |
Why?
|
| Head | 2 | 2020 | 51 | 0.330 |
Why?
|
| Vitronectin | 1 | 2008 | 6 | 0.330 |
Why?
|
| Drug Implants | 1 | 2008 | 9 | 0.320 |
Why?
|
| Middle Aged | 26 | 2020 | 11839 | 0.320 |
Why?
|
| Child | 16 | 2020 | 2442 | 0.310 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 291 | 0.300 |
Why?
|
| Embolization, Therapeutic | 1 | 2008 | 86 | 0.300 |
Why?
|
| Aged | 21 | 2020 | 10314 | 0.300 |
Why?
|
| Laminectomy | 1 | 2007 | 16 | 0.300 |
Why?
|
| Emotions | 2 | 2018 | 58 | 0.290 |
Why?
|
| Back Pain | 1 | 2007 | 28 | 0.290 |
Why?
|
| Telemetry | 5 | 2020 | 26 | 0.290 |
Why?
|
| Young Adult | 11 | 2019 | 2665 | 0.290 |
Why?
|
| Models, Biological | 2 | 2019 | 392 | 0.280 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2013 | 77 | 0.280 |
Why?
|
| Mutation | 3 | 2019 | 489 | 0.280 |
Why?
|
| Neuropsychological Tests | 8 | 2018 | 371 | 0.270 |
Why?
|
| Head Protective Devices | 5 | 2018 | 48 | 0.270 |
Why?
|
| Acceleration | 4 | 2020 | 65 | 0.260 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2016 | 29 | 0.250 |
Why?
|
| Gambling | 1 | 2004 | 6 | 0.250 |
Why?
|
| Carbon Radioisotopes | 3 | 2020 | 24 | 0.230 |
Why?
|
| Hippocampus | 2 | 2018 | 171 | 0.230 |
Why?
|
| Finite Element Analysis | 2 | 2019 | 82 | 0.230 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2013 | 22 | 0.220 |
Why?
|
| Temporal Bone | 2 | 2013 | 21 | 0.220 |
Why?
|
| Quinazolines | 2 | 2020 | 38 | 0.220 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 3990 | 0.210 |
Why?
|
| Sex Characteristics | 2 | 2014 | 173 | 0.210 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 582 | 0.210 |
Why?
|
| Rats | 9 | 2018 | 1596 | 0.210 |
Why?
|
| Retrospective Studies | 11 | 2020 | 3510 | 0.210 |
Why?
|
| Albuminuria | 4 | 2017 | 181 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2008 | 743 | 0.200 |
Why?
|
| Radiopharmaceuticals | 2 | 2020 | 93 | 0.200 |
Why?
|
| Atrophy | 3 | 2016 | 46 | 0.190 |
Why?
|
| Analysis of Variance | 4 | 2013 | 464 | 0.190 |
Why?
|
| Prefrontal Cortex | 2 | 2018 | 71 | 0.180 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2020 | 36 | 0.180 |
Why?
|
| Radiation Dosage | 1 | 2020 | 84 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 83 | 0.180 |
Why?
|
| Athletic Performance | 1 | 2020 | 12 | 0.180 |
Why?
|
| Diabetes Complications | 3 | 2018 | 177 | 0.180 |
Why?
|
| Whole-Body Irradiation | 1 | 2020 | 53 | 0.180 |
Why?
|
| Organ Size | 5 | 2018 | 218 | 0.170 |
Why?
|
| European Continental Ancestry Group | 4 | 2018 | 1166 | 0.170 |
Why?
|
| Hemiplegia | 1 | 2019 | 13 | 0.170 |
Why?
|
| Seasons | 2 | 2018 | 91 | 0.170 |
Why?
|
| Antibodies, Bispecific | 1 | 2019 | 6 | 0.170 |
Why?
|
| Spine | 1 | 2019 | 41 | 0.170 |
Why?
|
| Amyloid | 1 | 2019 | 15 | 0.170 |
Why?
|
| Diet, Mediterranean | 1 | 2019 | 31 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2017 | 3306 | 0.170 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 93 | 0.170 |
Why?
|
| Age of Onset | 1 | 2019 | 94 | 0.170 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 765 | 0.170 |
Why?
|
| Peptide Fragments | 2 | 2019 | 399 | 0.170 |
Why?
|
| Salvage Therapy | 1 | 2020 | 134 | 0.170 |
Why?
|
| Stress, Psychological | 2 | 2018 | 221 | 0.160 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 29 | 0.160 |
Why?
|
| Parkinsonian Disorders | 2 | 2019 | 9 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2016 | 53 | 0.160 |
Why?
|
| Body Weight | 2 | 2018 | 310 | 0.160 |
Why?
|
| Models, Anatomic | 1 | 2019 | 39 | 0.160 |
Why?
|
| Hyperemia | 2 | 2008 | 11 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 91 | 0.160 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 33 | 0.160 |
Why?
|
| Risk | 4 | 2020 | 321 | 0.160 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 41 | 0.150 |
Why?
|
| Dystonic Disorders | 2 | 2016 | 12 | 0.150 |
Why?
|
| Mental Recall | 1 | 2018 | 51 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 60 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 5 | 2017 | 308 | 0.150 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 99 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2018 | 355 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2018 | 83 | 0.150 |
Why?
|
| Neural Pathways | 2 | 2016 | 94 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2016 | 29 | 0.150 |
Why?
|
| Calcium | 1 | 2019 | 307 | 0.140 |
Why?
|
| Nootropic Agents | 1 | 2017 | 12 | 0.140 |
Why?
|
| Students | 1 | 2018 | 178 | 0.140 |
Why?
|
| Linear Models | 5 | 2018 | 449 | 0.140 |
Why?
|
| Cerebral Arteries | 2 | 2013 | 18 | 0.140 |
Why?
|
| Ataxia | 1 | 2016 | 8 | 0.140 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 95 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2018 | 379 | 0.130 |
Why?
|
| Primates | 1 | 2016 | 108 | 0.130 |
Why?
|
| Neoplasms | 2 | 2020 | 728 | 0.130 |
Why?
|
| Frontal Sinusitis | 1 | 2015 | 4 | 0.130 |
Why?
|
| Epidural Abscess | 1 | 2015 | 5 | 0.130 |
Why?
|
| Fever | 1 | 2015 | 61 | 0.120 |
Why?
|
| Skull Fractures | 2 | 2012 | 17 | 0.120 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2013 | 21 | 0.120 |
Why?
|
| Skull | 1 | 2014 | 48 | 0.120 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2014 | 2 | 0.120 |
Why?
|
| Siblings | 1 | 2014 | 25 | 0.120 |
Why?
|
| Radiology | 1 | 2014 | 41 | 0.120 |
Why?
|
| Apolipoproteins | 1 | 2016 | 200 | 0.120 |
Why?
|
| Equipment Design | 2 | 2018 | 171 | 0.120 |
Why?
|
| Ear, Inner | 1 | 2013 | 9 | 0.120 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 251 | 0.110 |
Why?
|
| Leukoaraiosis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Ocular Motility Disorders | 1 | 2013 | 3 | 0.110 |
Why?
|
| Ear | 1 | 2013 | 18 | 0.110 |
Why?
|
| Infant | 6 | 2013 | 1062 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2016 | 249 | 0.110 |
Why?
|
| Pattern Recognition, Automated | 1 | 2013 | 36 | 0.110 |
Why?
|
| Body Temperature | 2 | 2003 | 20 | 0.110 |
Why?
|
| Hematoma, Subdural | 1 | 2012 | 12 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2019 | 548 | 0.110 |
Why?
|
| Receptors, Drug | 2 | 2003 | 13 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2013 | 1270 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 224 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 132 | 0.110 |
Why?
|
| Calcinosis | 1 | 2013 | 146 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 765 | 0.100 |
Why?
|
| Quality of Life | 1 | 2018 | 946 | 0.100 |
Why?
|
| Fluoroscopy | 1 | 2012 | 40 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 37 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 50 | 0.100 |
Why?
|
| Atherosclerosis | 2 | 2015 | 766 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 408 | 0.100 |
Why?
|
| Maxillary Sinus | 1 | 2011 | 7 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 1542 | 0.090 |
Why?
|
| Facial Bones | 1 | 2011 | 10 | 0.090 |
Why?
|
| Facial Injuries | 1 | 2011 | 12 | 0.090 |
Why?
|
| Kidney Function Tests | 3 | 2016 | 107 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 246 | 0.090 |
Why?
|
| Motor Activity | 2 | 2003 | 325 | 0.090 |
Why?
|
| Accidents, Traffic | 1 | 2012 | 195 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2012 | 222 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 1497 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 26 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 543 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2009 | 8 | 0.080 |
Why?
|
| Tuberous Sclerosis | 1 | 2009 | 8 | 0.080 |
Why?
|
| Hypercapnia | 1 | 2008 | 4 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 42 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2008 | 18 | 0.080 |
Why?
|
| Age Factors | 3 | 2018 | 1189 | 0.080 |
Why?
|
| Platinum | 1 | 2008 | 21 | 0.080 |
Why?
|
| Hypoxia, Brain | 1 | 2008 | 4 | 0.080 |
Why?
|
| Deoxyglucose | 3 | 2003 | 16 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2008 | 97 | 0.080 |
Why?
|
| Materials Testing | 1 | 2008 | 89 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2018 | 1817 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2008 | 70 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2007 | 350 | 0.080 |
Why?
|
| Heterozygote | 2 | 2019 | 59 | 0.080 |
Why?
|
| Aging | 1 | 2014 | 946 | 0.080 |
Why?
|
| Dystonia | 2 | 2019 | 12 | 0.080 |
Why?
|
| Epilepsy | 1 | 2009 | 82 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2008 | 114 | 0.070 |
Why?
|
| Infusions, Intraosseous | 1 | 2007 | 1 | 0.070 |
Why?
|
| Occipital Lobe | 2 | 2017 | 5 | 0.070 |
Why?
|
| Cadaver | 1 | 2007 | 161 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 560 | 0.070 |
Why?
|
| United States | 4 | 2018 | 3976 | 0.070 |
Why?
|
| Blood Flow Velocity | 3 | 2013 | 77 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2019 | 604 | 0.070 |
Why?
|
| Memory | 2 | 2019 | 190 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2007 | 220 | 0.070 |
Why?
|
| Ethanol | 2 | 1998 | 189 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2003 | 67 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2014 | 94 | 0.060 |
Why?
|
| Creatinine | 2 | 2017 | 195 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2015 | 494 | 0.060 |
Why?
|
| Piperidines | 2 | 2003 | 118 | 0.060 |
Why?
|
| Time | 1 | 2004 | 23 | 0.060 |
Why?
|
| Risk Factors | 3 | 2020 | 3880 | 0.060 |
Why?
|
| Hypertension | 3 | 2017 | 960 | 0.060 |
Why?
|
| Time Factors | 4 | 2003 | 2151 | 0.060 |
Why?
|
| Depression | 2 | 2018 | 445 | 0.060 |
Why?
|
| Radiography | 2 | 2015 | 376 | 0.060 |
Why?
|
| Head Movements | 2 | 2013 | 13 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 633 | 0.060 |
Why?
|
| Locomotion | 1 | 2003 | 31 | 0.060 |
Why?
|
| Rotation | 2 | 2013 | 47 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 76 | 0.050 |
Why?
|
| Mice | 2 | 2019 | 2484 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 45 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2002 | 13 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 276 | 0.050 |
Why?
|
| Cocaine | 1 | 2003 | 256 | 0.050 |
Why?
|
| Running | 1 | 2020 | 19 | 0.040 |
Why?
|
| Ketone Bodies | 1 | 2019 | 8 | 0.040 |
Why?
|
| Mental Disorders | 2 | 2013 | 124 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 95 | 0.040 |
Why?
|
| HMGA2 Protein | 1 | 2019 | 13 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2019 | 26 | 0.040 |
Why?
|
| Disease Progression | 2 | 2014 | 594 | 0.040 |
Why?
|
| Movement Disorders | 1 | 2019 | 26 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 305 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 61 | 0.040 |
Why?
|
| China | 1 | 2018 | 50 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 93 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2019 | 81 | 0.040 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 1128 | 0.040 |
Why?
|
| Video Recording | 1 | 2018 | 59 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 107 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 434 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 164 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 99 | 0.040 |
Why?
|
| Sucrose | 1 | 1998 | 18 | 0.040 |
Why?
|
| Cell Line | 1 | 2019 | 435 | 0.040 |
Why?
|
| Ligands | 1 | 2018 | 81 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2017 | 3 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 322 | 0.040 |
Why?
|
| Personality | 1 | 2017 | 16 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 143 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 538 | 0.040 |
Why?
|
| Universities | 1 | 2018 | 150 | 0.040 |
Why?
|
| Autoradiography | 3 | 2003 | 45 | 0.040 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 18 | 0.040 |
Why?
|
| Survival Rate | 1 | 2020 | 877 | 0.040 |
Why?
|
| Anxiety | 1 | 2018 | 191 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 726 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 215 | 0.040 |
Why?
|
| tau Proteins | 1 | 2017 | 41 | 0.030 |
Why?
|
| Alcoholism | 1 | 1998 | 101 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2016 | 36 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 173 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 146 | 0.030 |
Why?
|
| Cerebellum | 1 | 2016 | 26 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 36 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 75 | 0.030 |
Why?
|
| Schools | 1 | 2016 | 67 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 257 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 684 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 525 | 0.030 |
Why?
|
| Forehead | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 120 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1199 | 0.030 |
Why?
|
| Edema | 1 | 2015 | 28 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 136 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1998 | 255 | 0.030 |
Why?
|
| Stroop Test | 1 | 2014 | 5 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 22 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 22 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 733 | 0.030 |
Why?
|
| Neck | 1 | 2014 | 27 | 0.030 |
Why?
|
| Albumins | 1 | 2014 | 45 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2265 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 83 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 228 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 510 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2013 | 29 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2014 | 116 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 105 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 517 | 0.030 |
Why?
|
| Nitrous Oxide | 1 | 2013 | 4 | 0.030 |
Why?
|
| Body Water | 1 | 2013 | 8 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2014 | 130 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 218 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 10 | 0.030 |
Why?
|
| Smoking | 1 | 2017 | 528 | 0.030 |
Why?
|
| Brain Death | 1 | 2013 | 26 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 27 | 0.030 |
Why?
|
| Swine | 1 | 2013 | 215 | 0.030 |
Why?
|
| Sample Size | 1 | 2012 | 38 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 1429 | 0.030 |
Why?
|
| Air Bags | 1 | 2012 | 15 | 0.030 |
Why?
|
| Occipital Bone | 1 | 2012 | 18 | 0.030 |
Why?
|
| Receptors, Cannabinoid | 2 | 2003 | 25 | 0.030 |
Why?
|
| Seizures | 1 | 2013 | 64 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2012 | 113 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2013 | 165 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 632 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 99 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2016 | 845 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 136 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 770 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 667 | 0.020 |
Why?
|
| Dementia | 1 | 2013 | 252 | 0.020 |
Why?
|
| Self Administration | 2 | 2003 | 297 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 401 | 0.020 |
Why?
|
| Hamartoma | 1 | 2009 | 10 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2009 | 29 | 0.020 |
Why?
|
| Contrast Media | 1 | 2009 | 138 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2008 | 38 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 10 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2008 | 31 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2008 | 15 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 86 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2008 | 38 | 0.020 |
Why?
|
| Homeostasis | 1 | 2008 | 132 | 0.020 |
Why?
|
| Glycolysis | 1 | 2003 | 20 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2003 | 32 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 2003 | 88 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2003 | 161 | 0.010 |
Why?
|
| Neocortex | 1 | 1998 | 4 | 0.010 |
Why?
|
| Limbic System | 1 | 1998 | 13 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1998 | 62 | 0.010 |
Why?
|
| Injections | 1 | 1998 | 64 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 79 | 0.010 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 1998 | 3 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1998 | 187 | 0.010 |
Why?
|